Vapor exposure to Δ9-tetrahydrocannabinol (THC) slows locomotion of the Maine lobster (Homarus americanus).


Journal

Pharmacology, biochemistry, and behavior
ISSN: 1873-5177
Titre abrégé: Pharmacol Biochem Behav
Pays: United States
ID NLM: 0367050

Informations de publication

Date de publication:
08 2021
Historique:
received: 27 05 2021
revised: 23 06 2021
accepted: 24 06 2021
pubmed: 2 7 2021
medline: 15 2 2022
entrez: 1 7 2021
Statut: ppublish

Résumé

Despite a long history of use in synaptic physiology, the lobster has been a neglected model for behavioral pharmacology. A restaurateur proposed that exposing lobster to cannabis smoke reduces anxiety and pain during the cooking process. It is unknown if lobster gill respiration in air would result in significant Δ The primary goal was to determine tissue THC levels in the lobster after exposure to THC vapor. Secondary goals were to determine if THC vapor altered locomotor behavior or nociception. Tissue samples were collected (including muscle, brain and hemolymph) from Homarus americanus (N = 3 per group) following 30 or 60 min of exposure to vapor generated by an e-cigarette device using THC (100 mg/mL in a propylene glycol vehicle). Separate experiments assessed locomotor behavior and hot water nociceptive responses following THC vapor exposure. THC vapor produced duration-related THC levels in all tissues examined. Locomotor activity was decreased (distance, speed, time-mobile) by 30 min inhalation of THC. Lobsters exhibit a temperature-dependent withdrawal response to immersion of tail, antennae or claws in warm water; this is novel evidence of thermal nociception for this species. THC exposure for 60 min had only marginal effect on nociception under the conditions assessed. Vapor exposure of lobsters, using an e-cigarette based model, produces dose-dependent THC levels in all tissues and reduces locomotor activity. Hot water nociception was temperature dependent, but only minimal anti-nociceptive effect of THC exposure was confirmed.

Identifiants

pubmed: 34197845
pii: S0091-3057(21)00121-0
doi: 10.1016/j.pbb.2021.173222
pmc: PMC9083469
mid: NIHMS1802860
pii:
doi:

Substances chimiques

E-Cigarette Vapor 0
Dronabinol 7J8897W37S

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

173222

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA035281
Pays : United States
Organisme : NIGMS NIH HHS
ID : K12 GM068524
Pays : United States
Organisme : NIAAA NIH HHS
ID : T32 AA007456
Pays : United States
Organisme : NIDA NIH HHS
ID : R44 DA041967
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA035482
Pays : United States
Organisme : NIDA NIH HHS
ID : K99 DA047413
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Psychopharmacology (Berl). 2022 May;239(5):1321-1335
pubmed: 34160641
Behav Processes. 2018 Jul;152:47-53
pubmed: 29549032
Drug Alcohol Depend. 2020 Jan 1;206:107733
pubmed: 31790978
Psychopharmacology (Berl). 2015 Aug;232(16):3033-43
pubmed: 25925779
Neuroscience. 2012 Jan 10;201:125-33
pubmed: 22138434
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Sep 15;905:85-95
pubmed: 22921635
Toxicol Appl Pharmacol. 1973 Jul;25(3):363-72
pubmed: 4199474
Neuropharmacology. 2019 Jun;151:127-135
pubmed: 30980837
Comp Biochem Physiol. 1964 Aug;12:509-25
pubmed: 14206963
J Pharmacol Exp Ther. 1987 May;241(2):521-6
pubmed: 3033218
Br J Pharmacol. 2012 May;166(2):510-21
pubmed: 22233379
J Neurobiol. 1992 Dec;23(10):1423-45
pubmed: 1487743
Br J Pharmacol. 2015 Apr;172(7):1783-91
pubmed: 25425111
J Neurosci. 2002 Mar 1;22(5):1874-82
pubmed: 11880517
Genes Cells. 2016 Jul;21(7):696-705
pubmed: 27193416
Neuropsychopharmacology. 2018 Jan;43(1):142-154
pubmed: 28875990
Front Physiol. 2018 Aug 03;9:1049
pubmed: 30123137
Drug Alcohol Depend. 2020 Sep 1;214:108166
pubmed: 32717503
Temperature (Austin). 2015 Feb 11;2(2):214-26
pubmed: 27227025
J Neurophysiol. 1984 Jun;51(6):1362-74
pubmed: 6145758
J Comp Physiol B. 2014 May;184(4):437-47
pubmed: 24604294
J Pharmacol Exp Ther. 2007 Mar;320(3):1097-105
pubmed: 17172531
Behav Brain Res. 2017 Aug 14;332:120-125
pubmed: 28583866
Ecotoxicol Environ Saf. 2015 May;115:291-9
pubmed: 25499691
Biol Open. 2015 Mar 27;4(4):441-8
pubmed: 25819841
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Eur J Pharmacol. 2007 Aug 13;569(1-2):70-6
pubmed: 17553486
Nature. 1997 Oct 23;389(6653):816-24
pubmed: 9349813
Neuropharmacology. 1988 Jul;27(7):737-42
pubmed: 2901683
BMC Genomics. 2020 Sep 22;21(1):649
pubmed: 32962631
Temperature (Austin). 2015 Feb 11;2(2):158-9
pubmed: 27227016
Front Cell Neurosci. 2020 Dec 09;14:615811
pubmed: 33362478
J Exp Biol. 1972 Feb;56(1):1-18
pubmed: 21046844
Science. 1977 Aug 12;197(4304):682-5
pubmed: 17776272
Neuropharmacology. 2016 Oct;109:112-120
pubmed: 27256501
Eur J Pharmacol. 2001 Oct 26;430(1):41-7
pubmed: 11698061
Neurosci Biobehav Rev. 2011 Oct;35(9):1847-53
pubmed: 21182861
Neurosci Lett. 2003 Dec 4;352(2):77-80
pubmed: 14625027
Sci Rep. 2021 Feb 25;11(1):4709
pubmed: 33633260
Channels (Austin). 2019 Dec;13(1):172-191
pubmed: 31096838
Psychopharmacology (Berl). 2018 Sep;235(9):2541-2557
pubmed: 29907926
Exp Clin Psychopharmacol. 2021 Feb;29(1):1-13
pubmed: 32297788
Front Mol Neurosci. 2019 Jan 15;11:487
pubmed: 30697147
J Neurophysiol. 1984 Jun;51(6):1375-93
pubmed: 6145759
J Neurophysiol. 1967 Jul;30(4):725-52
pubmed: 6035690
Drug Alcohol Depend. 2019 May 1;198:54-62
pubmed: 30878767
Top Companion Anim Med. 2013 Feb;28(1):8-12
pubmed: 23796481
J Neurosci. 2017 Mar 15;37(11):2859-2869
pubmed: 28188220

Auteurs

Arnold Gutierrez (A)

Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA; Department of Neuroscience, The Scripps Research Institute; La Jolla, CA, USA.

Kevin M Creehan (KM)

Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA; Department of Neuroscience, The Scripps Research Institute; La Jolla, CA, USA.

Mitchell L Turner (ML)

Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA; Colorado College, Colorado Springs, CO, USA.

Rachelle N Tran (RN)

Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA; University of Washington, Seattle, WA, USA.

Tony M Kerr (TM)

Department of Neuroscience, The Scripps Research Institute; La Jolla, CA, USA.

Jacques D Nguyen (JD)

Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA; Department of Neuroscience, The Scripps Research Institute; La Jolla, CA, USA.

Michael A Taffe (MA)

Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA; Department of Neuroscience, The Scripps Research Institute; La Jolla, CA, USA. Electronic address: mtaffe@ucsd.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH